Pulished Date August, 2019
ID: 591
Share on
Share on

Asia-Pacific Companion Diagnostics Market By Indication, By Technology & By Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: August, 2019
ID: 591
Pages: 140

APAC Companion Diagnostics Market Size & Growth (2019 – 2024)

Asia-Pacific Companion Diagnostics Market was worth USD 0.63 million in 2019 and estimated to be growing at a CAGR of 24.73%, to reach USD 1.89 million by 2024. 

Asia-Pacific ranks as the fastest growing market over the forecast period. Growth in the region is favoured by increasing population, increased spending on healthcare R&D by government and growing base of affluent middle class population.

Drivers and Restraints

Companion diagnostics are diagnostic tests used to increase effectiveness of the drug and for pre-determining the efficacy of the treatment. These products are mainly in-vitro devices or imaging tools, which are either developed after the drug is in the market or during drug development. Benefits provided by these products are providing crucial information on an individual’s risk factors for chronic conditions and enables health care professionals to decide whether drug it more beneficial over its risks or not.

Companion diagnostics have accompanied the development of personalized medicine, an advance approach in the clinical treatment process. Key factors driving the companion diagnostics market are accelerated drug regulatory approvals, merging new pharmaceuticals and diagnostics, improved efficacy profile of drugs and reduced healthcare expenditure. Complex clinical trial procedures are hindering the market growth.

This research report segmented and sub-segmented into the following categories:

  • By Indication: Oncology, Cardiovascular Diseases, Central Nervous System Disorders, Inflammation And Virology Diseases
  • By Technology: Immunohistochemistry, Molecular Diagnostics
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Due to rapid increase in population in developing countries like China and India are the fastest growing markets in this region.

The Top companies leading in the APAC Companion Diagnostics Market profiled in the report are:

Companies like,

  1. Abbott Molecular Inc.
  2. Roche Molecular Systems Inc.
  3. Leica Biosystems Nussloch GmbH
  4. bioMérieux Inc.
  5. Dako Inc.
  6. Qiagen Ltd.
  7. ARUP Laboratories
  8. Myriad Genetics Inc.
  9. Biogenex Laboratories Inc.
  10. Ventana Medical Systems Inc.
  11. Thermo Fisher Scientific Inc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Indications                            

                                5.1.1 Oncology 

                                                5.1.1.1 Colorectal Cancer

                                                5.1.1.2 Breast Cancer

                                                5.1.1.3 Lung Cancer

                                                5.1.1.4 Gastric Cancer

                                                5.1.1.5 Melanoma

                                5.1.2 Inflammation and Autoimmune Diseases  

                                5.1.3 Cardiovascular Diseases    

                                5.1.4 Central Nervous System Disorders               

                                5.1.5 Virology Diseases 

                5.2 By Technology                           

                                5.2.1 Immuno Histochemistry    

                                5.2.2 Molecular Diagnostics        

                                                5.2.2.1 In-Situ Hybridization

                                                5.2.2.2 Real Time PCR

                                                5.2.2.3 Gene Sequencing

6. Geographical Analysis                                              

                6.3 Asia-Pacific                 

                                6.1 Introduction               

                                6.2 China             

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea               

                                6.6 Australia      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Abbott Molecular Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Roche Molecular Systems Inc.                            

                8.3 Leica Biosystems Nussloch GmbH                     

                8.4 BioMérieux Inc.                        

                8.5 Dako Inc.                     

                8.6 Qiagen Ltd.                 

                8.7 ARUP Laboratories                  

                8.8 Myriad Genetics Inc.                              

                8.9 Biogenex Laboratories, Inc.                 

                8.10 Ventana Medical Systems Inc.                         

                8.11 Thermo Fisher Scientific Inc.                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Companion Diagnostics Market By Region, From 2019-2024 (USD million)
  2. Asia-Pacific Companion Diagnostics Market By Indication, From 2019-2024 (USD million)
  3. Asia-Pacific Oncology Market By Region, From 2019-2024 (USD million)
  4. Asia-Pacific Inflammation and Autoimmune Diseases Market By Region, From 2019-2024 (USD million)
  5. Asia-Pacific Cardiovascular Diseases Market By Region, From 2019-2024 (USD million)
  6. Asia-Pacific Central Nervous System Disorders Market By Region, From 2019-2024 (USD million)
  7. Asia-Pacific Virology Diseases Market By Region, From 2019-2024 (USD million)
  8. Asia-Pacific Companion Diagnostics Market By Technology, From 2019-2024 (USD million)
  9. Asia-Pacific Immuno Histochemistry Market By Region, From 2019-2024 (USD million)
  10. Asia-Pacific Molecular Diagnostics Market By Region, From 2019-2024 (USD million)
  11. Asia-Pacific Oncology Diagnostics Market By Type, From 2019-2024 (USD million)
  12. Asia-Pacific Colorectal Cancer Diagnostics Market By Region, From 2019-2024 (USD million)
  13. Asia-Pacific Breast Cancer Diagnostics Market By Region, From 2019-2024 (USD million)
  14. Asia-Pacific Lung Cancer Diagnostics Market By Region, From 2019-2024 (USD million)
  15. Asia-Pacific Gastric Cancer Diagnostics Market By Region, From 2019-2024 (USD million)
  16. Asia-Pacific Melanoma Diagnostics Market By Region, From 2019-2024 (USD million)
  17. Asia-Pacific Molecular Diagnostics Market By Type, From 2019-2024 (USD million)
  18. Asia-Pacific In-Situ Hybridization Market By Region, From 2019-2024 (USD million)
  19. Asia-Pacific Real Time PCR Market By Region, From 2019-2024 (USD million)
  20. Asia-Pacific Gene Sequencing Market By Region, From 2019-2024 (USD million)
  21. China Companion Diagnostics Market By Indication, From 2019-2024 (USD million)
  22. China Companion Diagnostics Market By Technology, From 2019-2024 (USD million)
  23. China Oncology Diagnostics Market By Type, From 2019-2024 (USD million)
  24. China Molecular Diagnostics Market By Type, From 2019-2024 (USD million)
  25. India Companion Diagnostics Market By Indication, From 2019-2024 (USD million)
  26. India Companion Diagnostics Market By Technology, From 2019-2024 (USD million)
  27. India Oncology Diagnostics Market By Type, From 2019-2024 (USD million)
  28. India Molecular Diagnostics Market By Type, From 2019-2024 (USD million)
  29. Japan Companion Diagnostics Market By Indication, From 2019-2024 (USD million)
  30. Japan Companion Diagnostics Market By Technology, From 2019-2024 (USD million)
  31. Japan Oncology Diagnostics Market By Type, From 2019-2024 (USD million)
  32. Japan Molecular Diagnostics Market By Type, From 2019-2024 (USD million)
  33. South Korea Companion Diagnostics Market By Indication, From 2019-2024 (USD million)
  34. South Korea Companion Diagnostics Market By Technology, From 2019-2024 (USD million)
  35. South Korea Oncology Diagnostics Market By Type, From 2019-2024 (USD million)
  36. South Korea Molecular Diagnostics Market By Type, From 2019-2024 (USD million)
  37. Australia Companion Diagnostics Market By Indication, From 2019-2024 (USD million)
  38. Australia Companion Diagnostics Market By Technology, From 2019-2024 (USD million)
  39. Australia Oncology Diagnostics Market By Type, From 2019-2024 (USD million)
  40. Australia Molecular Diagnostics Market By Type, From 2019-2024 (USD million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample